Medicare Monday: Provider consolidation drives up costs for patients and government
Two recent studies add to a growing body of research on how consolidation is driving up treatment costs.
Two recent studies add to a growing body of research on how consolidation is driving up treatment costs.
Two recent studies add to a growing body of research on how consolidation is driving up treatment costs. More and more cancer treatments are being administered at hospital outpatient facilities rather than physician offices, and this has real implications for costs.
When the site of care moves from a clinic to a hospital, costs are higher for both the patient and the health care system. With the government’s proposal to change how physicians are paid in Medicare Part B, this trend could be exacerbated, driving up costs for beneficiaries and the government. Here is what these studies found:
If harmful proposals like the Part B “demonstration” move forward, smaller physician offices will be discouraged from providing – and in some cases unable to provide – specialty treatments, like those for cancer, to seniors, potentially accelerating shifts in site-of-service. These analyses clearly show that proposals like the Part B “demonstration” are penny wise and pound foolish.
Learn more about the government proposed Medicare payment change here, and more on Medicare Part B at PhRMA.org/PartB.